Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Document › Details

Aptamer Group plc. (12/22/21). "Press Release: Admission to Trading on AIM and First Day of Dealings [Not for US, CA, AU, JP, et al.]".

	Region	United Kingdom (GB)
	Organisation	Aptamer Group plc (AIM: APTA)
	Group	Aptamer Group (Group)
	Organisation 2	Alternative Investment Market (AIM) (London)
	Group	London Stock Exchange plc (LSE)
	Product	Optimer® binders
	Product 2	investment banking
	Index term	Aptamer Group–SEVERAL: investment, 202112 IPO £10.8m net £9.1m with 9.2m new ordinary shares at £1.15/share
	Person	Tolley, Arron (Aptamer Group 2008– CEO + Co-Founder)
	Person 2	Courtman-Stock, Eleanor (Aptamer Group 202112 CFO)

Original document
accessed by [iito] on 2021-12-28

Record changed: 2023-06-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Aptamer Group (Group)

[1] Kollewe, Julia [The Guardian]. (12/20/21). "News: UK Biotech Firm Aptamer to Float Valued at £80.7m. York-based Company Makes Synthetic Antibodies for Pharmaceutical Firms including AstraZeneca"....
[2] Aptamer Group plc. (12/16/21). "Press Release: Placing and Proposed Admission to Trading on AIM [Not for US, CA, AU, JP, et al.]"....
[3] Aptamer Group Ltd.. (8/25/21). "Press Release: Aptamer Group and Bio-Works Technologies Partner to Enable Improved Solutions for Gene Therapy Manufacturing". York & Uppsala....
[4] Aptamer Group Ltd.. (1/7/19). "Press Release: Aptamer Group Announces Agreement with AstraZeneca to Explore Next-Generation Drug Delivery Devices"....
[5] Aptamer Group Ltd.. (6/29/18). "Press Release: Aptamer Group – UK Biotech Business Raises $2.2M Investment". York....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]